GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Nutrition, Elsevier BV, Vol. 33 ( 2017-01), p. 204-210
    Type of Medium: Online Resource
    ISSN: 0899-9007
    RVK:
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2017
    detail.hit.zdb_id: 2010168-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 38, No. 4_suppl ( 2020-02-01), p. 434-434
    Abstract: 434 Background: PET-CT is considered as standard modality for evaluating metastasis of esophageal cancer before treatment. On the other hand, it is unclear whether PET-CT CMR (complete metabolic response) could be useful for assessment after neoadjuvant chemotherapy. To clarify the utility of PET-CT CMR as an adequate modality of prediction for recurrence after neoadjuvant chemotherapy with DCF for esophageal cancer. Methods: Fifty-eight cases of esophageal cancer (cStageII-IVa) who received the esophagectomy with neoadjuvant chemotherapy of DCF since June 2013 in Oita University. We evaluated the clinicopathological factors, RFS and OS between CMR group (n=22, 38%) and non-CMR group (n=36, 62%). Results: In the clinical stage before chemotherapy, T-factor was higher in the non-CMR group (p = 0.044), but there were no significant differences of lymph node metastasis (p = 0.27) and stage (p = 0.94) between the two groups. There was no significant difference of the SUV max (16.4 ± 6.5 vs 15.7 ± 6.5, p = 0.98) of the main lesion before chemotherapy and the FDG accumulation rate of lymph nodes (14 cases (63.6%) vs 21 cases) (58.3%), p = 0.69) between the two groups. There were no significant differences of the surgical procedure, lymph node dissection area, number of harvested lymph nodes, amount of bleeding, operation time, curability, and intra/post-operative complications between the two groups. There were 5 cases (15%) with postoperative recurrence in the CMR group (lung 1 case, extra-regional lymph nodes 3 cases, bone 1 case), 17 cases (47%) in the non-CMR group (local 4 cases, lung 3 cases, livers 5 cases, extra regional lymph nodes 6 cases, bone 4 cases, pleura 2 cases), but there was no significant difference between the two groups (p = 0.062). There were significant differences between the two groups for 3-year RFS (81.3 vs 65.3 months, p=0.021) and 3-year OS (93.8 vs 61.6 months, p=0.011). Conclusions: PET-CR CMR could not predict recurrence at present. PET-CR CMR cases had better prognosis compared to non-CMR cases in terms of 3-year RFS and 3-years OS.
    Type of Medium: Online Resource
    ISSN: 0732-183X , 1527-7755
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Clinical Oncology (ASCO)
    Publication Date: 2020
    detail.hit.zdb_id: 2005181-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 35, No. 15_suppl ( 2017-05-20), p. e14635-e14635
    Abstract: e14635 Background: This is a following report of the exploratory phase II study of adjuvant peptide vaccine for thoracic esophageal squamous cell carcinoma (TESCC) (abstract #3087 in ASCO2016), focusing on an association of immunological responses with clinical outcomes. Three HLA-A-24-restricted epitope peptides derived from cancer-testis antigens, up-regulated lung cancer 10 (URLC10), cell division cycle associated 1 (CDCA1) and KH domain-containing protein overexpressed in cancer 1 (KOC1), were used in this study. Methods: TESCC patients who underwent neoadjuvant therapy followed by curative resection (Dec./2009 to Sep./2014) and were found LN metastasis were enrolled. One mg each of three peptides mixed with Montanide was injected to patients with HLA-A*2402 20 times in a 6-months period. No other adjuvant therapy was given until recurrence occurred. Primary endpoint is relapse-free survival (RFS). Immunological responses were examined by ELISPOT assay and immunohistochemistry (IHC). Results: 33 patients were enrolled in the vaccine group (VG) and 30 with non-HLA-A*2402 were used as controls (CG). There was no significant difference in clinical backgrounds between the two groups. 5-year RFS in the VG was 44.6% while that in the CG group was 31.6% (p = 0.207); patients who showed CD8+ CTL induction to multiple peptides tend to show better RFS rate [3/2/1 peptides = 69.0(n = 20)/46.8(n = 11)/0%(n = 2), respectively]. Five-year esophageal cancer-specific survival (ECSS) were 58.4% in the VG compared with 35.4% in the CG (p = 0.156); 90.0% (n = 11) vs. 50.0% (n = 15) and 43.8% (n = 22) vs. 24.0%(n = 15) in pN1 and pN2-3 groups, respectively. Regarding the CD8+ positivity, ECSS was improved only in the negative group (56.6% in VG vs. 26.7% in CG). Classification by T cell positivity and PD-L1 expression [type I(+/+), II(-/-), III(-/+) and IV(+/-)] showed 5-year ECSS to be 100%(n = 3), 66.4%(n = 19), 20.0%(n = 5) and 44.4%(n = 6). Conclusions: Our cancer peptide vaccines induced the antigen-specific CD8+ T cell highly and efficiently, and suppressed recurrence with the strong immune responses. Clinical trial information: UMIN000003557.
    Type of Medium: Online Resource
    ISSN: 0732-183X , 1527-7755
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Clinical Oncology (ASCO)
    Publication Date: 2017
    detail.hit.zdb_id: 2005181-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Cancer Science, Wiley
    Abstract: Neoadjuvant chemotherapy (NAC) followed by surgery is one of the standard therapeutic approaches in Japan for patients with locally advanced esophageal carcinoma. Recently, the JCOG1109 study revealed that NAC with docetaxel, cisplatin and 5‐fluorouracil (5‐FU) (DCF‐NAC) is superior to NAC with cisplatin and 5‐FU, and has now become the standard preoperative chemotherapy. Using a microarray system, we have previously investigated the expression profiles of endoscopic biopsy samples from patients with esophageal squamous cell carcinoma (ESCC) before DCF‐NAC (preNAC) and identified 17 molecules as biomarkers predictive of a pathologically complete response to DCF‐NAC. Here, we re‐grouped our previous dataset based on the histopathological response grade with the addition of several microarray profiles and conducted a re‐analysis using bioinformatic web tools including DAVID, GSEA, UALCAN, and CIBERSORTx. We identified 204 genes that were differentially expressed between the highly resistant and sensitive groups. Some of these differentially expressed genes (DEGs) were related to the immune response and showed higher expression in the sensitive group. UALCAN showed that high expression of 28 of the top 50 DEGs was associated with a favorable prognosis ( p   〈  0.25), and that this reached a significant ( p   〈  0.05) level for 18 of them, suggesting that patients with high expression of these genes might have benefited from chemotherapy and thus had a better outcome. In preNAC biopsy tissues from a DCF‐sensitive case, we demonstrated the presence of cells expressing mRNA for CXCL9 , one of the prognosis‐related DEGs. Our results highlight the association of immune‐related expression profile in preNAC ESCC with the DCF‐NAC efficacy.
    Type of Medium: Online Resource
    ISSN: 1347-9032 , 1349-7006
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2115647-5
    detail.hit.zdb_id: 2111204-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: ECS Meeting Abstracts, The Electrochemical Society, Vol. MA2015-02, No. 24 ( 2015-07-07), p. 959-959
    Abstract: Introduction In order to promote the introduction of renewable energy, large-scale energy storage and transportation systems are required. Hydrogen is expected to apply for the energy storage and transportation. Organic chemical hydride materials are prospective energy carriers to solve the issue of hydrogen’s low volumetric energy density. Among them, toluene (TL)/methylcyclohexane (MCH) system has been focused due to the easy handling and the low toxicity. Recently, researches of one-step electrolytic hydrogenation of TL have just been started [1] . DSA ® type anodes composed of IrO 2 -based electrocatalyst coated on Ti which have excellent activity and extremely high durability for oxygen evolution reaction (OER) [2] is required as a counter electrode of electrolytic process. It is well known that some organic additive lead serious degradation of the anodes [3] . IrO 2 -Ta 2 O 5 /Ti would be a good candidate, because the overpotential of IrO 2 -Ta 2 O 5 /Ti in sulfuric acid with organic compound contamination is lower than that of IrO 2 /Ti [3] . However, the OER activity of IrO 2 -Ta 2 O 5 /Ti would not still be enough and the effect of TL and MCH on the activity and durability have not been clarified. In this study, activity of IrO 2 -Ta 2 O 5 based Ti electrodes whose Ta is replaced by Zr was investigated in sulfuric acid with TL contamination. Experimental The precursor of the electrocatalyst was n-butanol solution of H 2 IrCl 6 ・6H 2 O, Ta(C 4 H 9 O) 5 and Zr(C 4 H 9 O) 4 with nominal composition of Ir: Ta: Zr= 50: (50- X ): X (0 ≦ X 〈 50) in mole fraction. A pretreated Ti plate was dipped in the precursor, and dried at 100 o C for 10 min. Then it was thermally decomposed at 500 o C for 10 min. The process of the dipping, drying, and decomposition were repeated several times to get around 10 g m -2 of IrO 2 loading. Finally, it was baked at 500 o C for 1h. The loading was evaluated by a X-ray fluorescent analysis.    Polarization of the OER was evaluated with 5 mV s -1 of potential sweep between 1.2 and 2.0 V vs. RHE in 1 M H 2 SO 4 with and without saturated TL at 60 o C. A counter electrode and a reference electrode were platinum wire and reversible hydrogen electrode, respectively. Resistance of the electrolyte and double layer capacitance was evaluated with AC impedance method. Results and discussion    Double layer capacitance ( C dl ) of IrO 2 /Ti, Ir 50 Ta 50 -Oxide/Ti and Ir 50 Ta 20 Zr 30 -Oxide/Ti anodes in 1 M H 2 SO 4 at 60 o C were 2.1, 25, and 75 mF cm -2 , respectively. The C dl of the Ir 50 Ta 20 Zr 30 -Oxide/Ti was three times larger than that of Ir 50 Ta 50 -Oxide/Ti which was ten times larger than the IrO 2 /Ti. The C dl corresponds to the real surface area for precious metal oxide coated electrode [4] . Therefore, Ta and Zr additives increase the real surface area of the IrO 2 based coating, and the ternary system would increase real surface area compared to the binary system. The polarization curves for OER current density on IrO 2 /Ti, Ir 50 Ta 50 -Oxide/Ti and Ir 50 Ta 20 Zr 30 -Oxide/Ti in 1 M H 2 SO 4 with and without saturated TL were shown in Fig. 1. The current densities in Tafel region were 0.9, 13, and 115 mA cm -2 at 1.55 V vs. RHE in 1 M H 2 SO 4 at 60 o C for IrO 2 /Ti, Ir 50 Ta 50 -Oxide/Ti and Ir 50 Ta 20 Zr 30 -Oxide/Ti, respectively. The large potential reduction more than 100mV at 100 mA cm -2 was obtained with Ir 50 Ta 20 Zr 30 -Oxide/Ti compared to the others, reflecting their C dl values. While the current density of IrO 2 /Ti decreased by 43% with TL contamination, the others decreased by 10% or less with TL contamination. The current densities based on C dl on Ir 50 Ta (50- X ) Zr X -Oxide/Ti at 1.55 V vs. RHE in 1 M H 2 SO 4 with and without saturated TL were shown in Fig. 2. They increased with Zr content, and the decrement of current density by TL contamination was kept constant in spite of change in Zr content. TL would decrease the current density of OER with the adsorption onto IrO 2 . However, the addition of Ta might prevent the adsorption of TL onto IrO 2 due to the catalytic contribution on Ir and the addition of Zr might mainly increase the real surface area without changing the Ta effect. Acknowledgments This work was supported by Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), “energy carrier” (Funding agency: JST). We applicate the person concerned them. References S. Mitsushima, Y. Takakuwa, K. Nagai, Y. Kohno, K. Matsuzawa, Proceedings of the Grand Renewable Energy 2014 , O-Hf-5-1(2014). J. Krysa, L. Kule, R. Mraz, I. Rousar, J. Appl. Electrochem , 26 , 999(1996). M. Takahashi, Soda to Enso , 12 , 531(1988). L.A. da Silva, V.A. Alves, M.A.P. da Silva, S. Trasatti and J.F.C. Boodtst, Electrochem . Acta , 42 , 272 (1997). Figure 1
    Type of Medium: Online Resource
    ISSN: 2151-2043
    Language: Unknown
    Publisher: The Electrochemical Society
    Publication Date: 2015
    detail.hit.zdb_id: 2438749-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Journal of Computational Science, Elsevier BV, Vol. 49 ( 2021-02), p. 101277-
    Type of Medium: Online Resource
    ISSN: 1877-7503
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2021
    detail.hit.zdb_id: 2557360-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Annals of Surgery, Ovid Technologies (Wolters Kluwer Health), Vol. 275, No. 1 ( 2022-01), p. e155-e162
    Abstract: To elucidate the efficacy of adjuvant vaccine monotherapy using 3 Human Leukocyte Antigen (HLA)-A ∗ 24-restricted tumor-specific peptide antigens for ESCC, upregulated lung cancer 10, cell division cycle associated 1, and KH domain-containing protein overexpressed in cancer 1. Summary of Background Data: ESCC patients with pathologically positive nodes (pN(+)) have a high risk for postoperative recurrence, despite curative resection after preoperative therapy. Subclinical micrometastases are an appropriate target for cancer vaccine. Methods: This is a non-randomized prospective phase II clinical trial (UMIN000003557). ESCC patients curatively resected after preoperative therapy with pN(+) were allocated into the control and vaccine groups (CG and VG) according to the HLA-A status. One mg each of three epitope peptides was postoperatively injected 10 times weekly followed by 10 times biweekly to the VG. The primary and secondary endpoints were relapse-free survival (RFS) and esophageal cancer-specific survival (ECSS), respectively. Results: Thirty were in the CG and 33 in the VG. No significant difference was observed in RFS between the CG and VG (5-year RFS: 32.5% vs 45.3%), but the recurrence rate significantly decreased with the number of peptides which induced antigen-specific cytotoxic T lymphocytes. The VG showed a significantly higher 5-year ECSS than the CG (60.0% vs 32.4%, P = 0.045) and this difference was more prominent in patients with CD8 + and programmed death-ligand 1 double negative tumor (68.0% vs 17.7%, P = 0.010). Conclusions: Our cancer peptide vaccine might improve the survival of ESCC patients, which is warranted to be verified in the phase III randomized controlled study.
    Type of Medium: Online Resource
    ISSN: 0003-4932 , 1528-1140
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2022
    detail.hit.zdb_id: 2641023-0
    detail.hit.zdb_id: 2002200-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Physical Chemistry Chemical Physics, Royal Society of Chemistry (RSC), Vol. 24, No. 22 ( 2022), p. 13514-13518
    Abstract: Pentacene derivatives with both π-radical- and TIPS-substituents (1m and 1p) were synthesized and their photochemical properties and excited-state dynamics were evaluated. The pentacene-radical-linked systems 1m (1p) showed a remarkable improvement in photochemical stability, which was 187 (139) times higher than that of 6,13-bis(triisopropylsilylethynyl)pentacene. Transient absorption spectroscopy showed that this remarkable photostabilization is due to the ultrafast intersystem crossing induced by effective π-conjugation between the radical substituent and pentacene moiety. The relationship between π-topology and the photochemical stability is also discussed based on the excited-state dynamics.
    Type of Medium: Online Resource
    ISSN: 1463-9076 , 1463-9084
    Language: English
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date: 2022
    detail.hit.zdb_id: 1476283-3
    detail.hit.zdb_id: 1476244-4
    detail.hit.zdb_id: 1460656-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Targeted Oncology, Springer Science and Business Media LLC, Vol. 8, No. 4 ( 2013-12), p. 231-235
    Type of Medium: Online Resource
    ISSN: 1776-2596 , 1776-260X
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2013
    detail.hit.zdb_id: 2222136-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Diseases of the Esophagus, Oxford University Press (OUP), Vol. 34, No. Supplement_1 ( 2021-09-17)
    Abstract: Esophageal squamous cell carcinoma (ESCC) patients with pathologically positive nodes have a high risk for postoperative recurrence, despite curative resection after preoperative therapy. Subclinical micrometastases are an appropriate target for cancer vaccine. To elucidate the efficacy of adjuvant vaccine monotherapy using three HLA-A*24-restricted tumor-specific peptide antigens for ESCC, up-regulated lung cancer 10, cell division cycle associated 1 and KH domain-containing protein overexpressed in cancer 1, we conducted an exploratory prospective phase II clinical trial (UMIN000003557). Methods Patients with ESCC who underwent curative resection after preoperative therapy and were found pathologically positive lymph node metastasis were enrolled from December 2009 to September 2014 and allocated into the control and vaccine groups (CG and VG) based on the HLA-A*2402 positive or negative. One mg each of three epitope peptides mixed with 1 mL of Montanide ISA 51 VG was administered the first 10weekly injections followed by 10 additional biweekly injections to VG. No other adjuvant therapy was given until recurrence occurred. The primary endpoint was relapse-free survival (RFS) and the secondary endpoint was esophageal cancer-specific survival (ECSS). Results Thirty were in the CG and 33 in the VG. No significant difference was observed in RFS between the CG and VG (5-year RFS: 32.5% vs. 45.3%, p = 0.205 (one-sided)), but the recurrence rate significantly decreased with the number of peptides which induced antigen-specific cytotoxic T lymphocytes. The VG showed a significantly higher 5-year ECSS than the CG (60.0% vs. 32.4%, p = 0.045 (one-sided)) probably due to the better clinical responses in patients of the VG to the post-recurrence therapy and this difference was more prominent in patients with CD8+ and programmed death-ligand 1 double negative tumor (68.0% vs. 17.7%, p = 0.010 (two-sided)). Conclusion Our results suggested that the cancer peptide vaccine suppressed the postoperative recurrence, enhanced the post-recurrence therapy and improved the survival of ESCC patients, particularly in the cases without CD8 infiltration and PD-L1 expression. A phase III randomized controlled study has been conducted in response to these results, and the results are waiting to be published.
    Type of Medium: Online Resource
    ISSN: 1120-8694 , 1442-2050
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2021
    detail.hit.zdb_id: 2004949-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...